Forxiga Tablets Specific Clinical Experience Investigation for Elderly
Phase of Trial: Phase IV
Latest Information Update: 28 Oct 2016
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors AstraZeneca
- 20 May 2016 Status changed from active, no longer recruiting to completed.
- 15 Oct 2015 Planned End Date changed from 1 Oct 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 15 Oct 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.